(Q44421418)

English

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

scientific article published on 4 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection (English)

1 reference

Europe PubMed Central

2 December 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yun-Fan Sun

1

1 reference

Europe PubMed Central

2 December 2017

Yang Xu

2

1 reference

Europe PubMed Central

2 December 2017

Xin-Rong Yang

3

1 reference

Europe PubMed Central

2 December 2017

Wei Guo

4

1 reference

Europe PubMed Central

2 December 2017

Xin Zhang

5

1 reference

Europe PubMed Central

2 December 2017

Shuang-Jian Qiu

6

1 reference

Europe PubMed Central

2 December 2017

Ruo-Yu Shi

7

1 reference

Europe PubMed Central

2 December 2017

Bo Hu

8

1 reference

Europe PubMed Central

2 December 2017

Jian Zhou

9

1 reference

Europe PubMed Central

2 December 2017

Jia Fan

10

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

4 March 2013

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

57

1 reference

Europe PubMed Central

2 December 2017

4

1 reference

Europe PubMed Central

2 December 2017

1458-1468

1 reference

Europe PubMed Central

2 December 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Predictors and patterns of recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Detection, clinical relevance and specific biological properties of disseminating tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Tumor self-seeding by circulating cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

The cancer stem cell: premises, promises and challenges

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Circulating breast cancer cells are frequently apoptotic

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Apoptosis of circulating tumor cells in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

21 January 2018

Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

[Pitfalls in the classification of liver tumors]

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26151

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26151

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44421418&oldid=2033102308"